Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Duke University
University of Rochester
Scripps Translational Science Institute
Roswell Park Cancer Institute
Shwachman-Diamond Syndrome Alliance Inc
Fred Hutchinson Cancer Center
CHU de Reims
Wake Forest University Health Sciences
University of California, San Francisco
Columbia University
New York Medical College
Columbia University